CMND Clearmind Medicine Inc.
Price Chart
Executive Summary
Clearmind Medicine announced a live webinar on June 10, 2026, featuring investigators from Yale and Johns Hopkins to discuss clinical data from its Phase I/IIa trial of CMND-100 (MEAI) for Alcohol Use Disorder. The press release contains no new financial data, clinical results, or regulatory milestones — it is a routine investor-relations event.
Actionable Insight
The webinar may provide color on the Phase I/IIa trial, but no material catalyst is announced. Traders should monitor for any data readouts or regulatory updates in future filings; this event alone is unlikely to move the stock.
Key Facts
- Webinar scheduled for June 10, 2026, 12:00–1:00 PM EDT.
- Speakers include Dr. Anahita Bassir Nia (Yale) and Dr. Jennifer Ellis (Johns Hopkins).
- CEO Dr. Adi Zuloff-Shani will provide a clinical development and corporate update.
- No new clinical data, financial results, or regulatory decisions were disclosed in the press release.
- Company market cap is approximately $3M, reflecting early-stage biotech risk.
Financial Impact
No financial impact disclosed; webinar is a routine investor relations event.
Risk Factors
- No new clinical data or regulatory milestones announced — the webinar may not produce material news.
- Early-stage biotech with $3M market cap carries high risk of dilution or failure.
- Historical performance on CMND shows high volatility with negative average returns at T+5.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3307314 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
3
| $3.36 awaiting T+5 | awaiting T+5 | — | $3.34 (−0.60%) |
|
Jun 5, 2026
10d ago
|
Press Release
| $2.76 awaiting T+5 | awaiting T+5 | — | $3.34 (+21.01%) |
|
May 29, 2026
17d ago
|
6-K
| $3.58 $2.91 | ▼ −18.72% | ▼ −18.42% | $3.34 (−6.70%) |
|
May 29, 2026
17d ago
|
Press Release
| $3.58 $2.91 | ▼ −18.72% | ▼ −18.42% | $3.34 (−6.70%) |
|
May 26, 2026
20d ago
|
6-K
| $2.59 $3.17 | ▲ +22.39% | ▲ +21.31% | $3.34 (+28.96%) |
|
May 26, 2026
20d ago
|
Press Release
| $2.59 $3.17 | ▲ +22.39% | ▲ +21.31% | $3.34 (+28.96%) |
|
May 19, 2026
27d ago
|
6-K
| $2.36 $2.58 | ▼ −9.28% | ▼ −7.04% | $3.34 (−41.53%) |
|
May 19, 2026
27d ago
|
6-K
| $2.36 $2.58 | ▲ +9.28% | ▲ +7.04% | $3.34 (+41.53%) |
|
May 19, 2026
27d ago
|
Press Release
| $2.36 $2.58 | ▼ −9.28% | ▼ −7.04% | $3.34 (−41.53%) |
|
May 18, 2026
27d ago
|
6-K
| $2.36 $2.58 | ▼ −9.28% | ▼ −7.04% | $3.34 (−41.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access